Does COVID-19 infection increase the risk of Guillain-Barré?
Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the online issue of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the disorder in the next six weeks than people who did not...
Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the online issue of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the disorder in the next six weeks than people who did not receive the mRNA vaccine.
Guillain-Barré syndrome is a rare autoimmune disorder in which the immune system attacks nerve cells. Symptoms start with weakness in the hands and feet and may progress to paralysis.
The study involved over 3 million people in Israel with no previous diagnosis of Guillain-Barré.
Then researchers looked to see whether participants had a COVID infection or a COVID vaccine during the six weeks prior to the diagnosis of Guillain-Barré or the same time period for their matched participants.
Researchers determined that people with a recent COVID infection were six times more likely to develop Guillain-Barré than those without a recent infection. A total of 12% of the people with Guillain-Barré had a recent COVID infection, compared to 2% of the people who did not have Guillain-Barré.In addition, 11% of those with Guillain-Barré had a recent vaccination with a mRNA vaccine, compared to 18% of those who did not have Guillain-Barré.
They also found that people with a recent mRNA vaccination were more than 50% less likely to develop Guillain-Barré than those without a recent mRNA vaccination.
Reference: AMERICAN ACADEMY OF NEUROLOGY, Neurology
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd